Article Details
Retrieved on: 2025-03-11 20:12:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ViiV HEALTHCARE SHOWCASES LEADERSHIP IN LONG-ACTING INJECTABLES INNOVATION AT CROI 2025 WITH DATA ON THIRD-GENERATION INTEGRASE INHIBITOR (INSTI) ...
Article found on: viivhealthcare.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here